feed,title,long_url,short_url
Benzinga,Is Axon a Buy as Wall Street Analysts Look Optimistic?,https://benzinga.com/news/earnings/24/08/40193391/is-axon-a-buy-as-wall-street-analysts-look-optimistic,https://da.gd/vads
Benzinga,Enfusion Q2 Earnings: Taking a Look at Key Metrics Versus Estimates,https://benzinga.com/news/earnings/24/08/40193387/enfusion-q2-earnings-taking-a-look-at-key-metrics-versus-estimates,https://da.gd/F2eJfZ
Benzinga,4 Stocks That Flaunt an Impressive Interest Coverage Ratio,https://benzinga.com/news/earnings/24/08/40195840/4-stocks-that-flaunt-an-impressive-interest-coverage-ratio,https://da.gd/XK92
Benzinga,What's in the Cards for Expedia Group in Q2 Earnings?,https://benzinga.com/news/earnings/24/08/40195829/whats-in-the-cards-for-expedia-group-in-q2-earnings,https://da.gd/XAkBE
